<code id='9459AD814E'></code><style id='9459AD814E'></style>
    • <acronym id='9459AD814E'></acronym>
      <center id='9459AD814E'><center id='9459AD814E'><tfoot id='9459AD814E'></tfoot></center><abbr id='9459AD814E'><dir id='9459AD814E'><tfoot id='9459AD814E'></tfoot><noframes id='9459AD814E'>

    • <optgroup id='9459AD814E'><strike id='9459AD814E'><sup id='9459AD814E'></sup></strike><code id='9459AD814E'></code></optgroup>
        1. <b id='9459AD814E'><label id='9459AD814E'><select id='9459AD814E'><dt id='9459AD814E'><span id='9459AD814E'></span></dt></select></label></b><u id='9459AD814E'></u>
          <i id='9459AD814E'><strike id='9459AD814E'><tt id='9459AD814E'><pre id='9459AD814E'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:174
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more
          Prior authorization will have to move faster under new Biden rule
          Prior authorization will have to move faster under new Biden rule

          AdobeTheBidenadministrationmovedWednesdaytoforceinsurancecompaniestogivespecificreasonsfordenyingcov

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Study suggests Covid rebound is far more common with Paxlovid than without

          AdobeAsmallandpreliminarystudypublishedMondayseemstoindicatethatpatientsreceivingthedrugPaxlovidaref